BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260921T110000
DTEND;TZID=America/Los_Angeles:20260921T120000
DTSTAMP:20260831T214603Z
CREATED:20260831T214603Z
LAST-MODIFIED:20260831T214603Z
UID:11193-1789988400-1789992000@thebiocalendar.com
SUMMARY:Beyond the Starting Material: Building a Path to GMP Manufacturing Success
DESCRIPTION:For cell therapy developers\, manufacturing success starts well before a process enters a GMP cleanroom. Decisions around donor and material sourcing\, collection strategy\, starting material specifications\, process development\, and analytical strategy can directly influence process consistency\, technology transfer\, and manufacturing readiness. \nJoin technical experts from New York Blood Center Enterprises’ Comprehensive Cell Solutions (CCS) team for a practical discussion on connecting cellular starting materials with downstream process development and GMP manufacturing. Drawing on real-world experience across sourcing\, collections\, process and analytical development\, technology transfer\, and clinical manufacturing\, the panel will highlight key considerations and common challenges that arise as programs move from early development toward the clinic through commercialization. \nThe discussion will explore how teams can better align starting material requirements with the manufacturing process\, establish appropriate controls and specifications\, prepare processes for successful technology transfer\, and build a more reliable path into GMP manufacturing. Attendees will leave with practical considerations for reducing variability\, anticipating manufacturing challenges\, and making development decisions with later-stage requirements in mind. \nKey Learning Objectives \n\nUnderstand the role of starting material in process performance and how donor criteria\, collection strategy\, material attributes\, and variability should be considered during development\nIdentify key considerations when moving a process into GMP manufacturing\, including process and analytical readiness\, technology transfer\, facility fit\, and operational execution\nLearn how early development decisions can support later-stage manufacturing\, helping teams anticipate risks\, improve process robustness\, and prepare for clinical and commercial requirements
URL:https://thebiocalendar.com/event/beyond-the-starting-material-building-a-path-to-gmp-manufacturing-success/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/092126_comprehensive_reg_1920x250_0.png
END:VEVENT
END:VCALENDAR